India Contraceptive Market Size & Outlook, 2024-2030
Related Markets
India contraceptive market highlights
- The India contraceptive market generated a revenue of USD 1,692.1 million in 2024 and is expected to reach USD 2,429.9 million by 2030.
- The India market is expected to grow at a CAGR of 6.2% from 2025 to 2030.
- In terms of segment, contraceptive devices was the largest revenue generating product in 2024.
- Contraceptive Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Contraceptive market data book summary
| Market revenue in 2024 | USD 1,692.1 million |
| Market revenue in 2030 | USD 2,429.9 million |
| Growth rate | 6.2% (CAGR from 2025 to 2030) |
| Largest segment | Contraceptive devices |
| Fastest growing segment | Contraceptive Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Contraceptive Drugs, Contraceptive Devices |
| Key market players worldwide | Bayer AG, Cupid, Helm AG, Church & Dwight Co Inc, Organon & Co Ordinary Shares, Pfizer Inc, Viatris Inc, AbbVie Inc, Afaxys, Veru Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals, China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S, Crinetics Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, India accounted for 5.4% of the global contraceptive market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China contraceptive market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 405.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Contraceptive Market Scope
Contraceptive Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | View profile | 210 | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 | https://www.crinetics.com |
| China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | View profile | 72986 | 26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, Hong Kong | https://www.crpharm.com |
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| Helm AG | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://www.helmag.com |
| Cupid | View profile | 51-100 | Nasik, Maharashtra, India, Asia | https://www.cupidlimited.com |
| Afaxys | View profile | 1-10 | Charleston, South Carolina, United States, North America | https://www.afaxys.com/ |
| Veru Inc | View profile | 233 | 2916 North Miami Avenue, Suite 1000, Miami, FL, United States, 33127 | https://www.verupharma.com |
| Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
| Organon & Co Ordinary Shares | View profile | 10000 | 30 Hudson Street, Floor 33, Jersey City, NJ, United States, 07302 | https://www.organon.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Church & Dwight Co Inc | View profile | 5550 | 500 Charles Ewing Boulevard, Ewing, NJ, United States, 08628 | https://www.churchdwight.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
India contraceptive market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to contraceptive market will help companies and investors design strategic landscapes.
Contraceptive devices was the largest segment with a revenue share of 57.8% in 2024. Horizon Databook has segmented the India contraceptive market based on contraceptive drugs, contraceptive devices covering the revenue growth of each sub-segment from 2018 to 2030.
India contraceptive drugs and devices market is experiencing significant growth, driven by increasing awareness of family planning, government initiatives, and a rising demand for effective contraceptive solutions.
The country has seen significant advancements in contraceptive options with the launch of new drugs and devices aimed at enhancing family planning services. For instance, in July 2024, the health department initiated a pilot project in four districts, introducing subdermal implants that provide effective contraception for up to three years.
These implants are part of efforts to enhance contraceptive options available to women in specific regions. Subdermal implants are now offered at SMS Medical College in Jaipur and RNT Medical College in Udaipur.
Reasons to subscribe to India contraceptive market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India contraceptive market databook
-
Our clientele includes a mix of contraceptive market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India contraceptive market , including forecasts for subscribers. This country databook contains high-level insights into India contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India contraceptive market size, by product, 2018-2030 (US$M)
India Contraceptive Market Outlook Share, 2024 & 2030 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
